サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1347577

遺伝子検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遺伝子検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界の遺伝子検査市場規模は2022年に159億米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に10.37%の成長率（CAGR）を示し、2028年までに290億米ドルに達すると予測しています。

遺伝子検査、またはデオキシリボ核酸（DNA）検査は、染色体構造またはDNA配列の変化を特定する医療技術を指します。これには、実験室での遺伝的状態や、様々な遺伝性疾患の発症や遺伝の可能性を調べるための、個々の血液サンプルの採取と分析が含まれます。遺伝子検査は、遺伝子の突然変異に関する正確な結果を提供し、不必要な検診の必要性をなくし、健康管理のために十分な情報に基づいた決定を下すことを支援します。現在、遺伝子検査は、キャリア検査、診断検査、予測検査、症候前検査、出生前検査など、さまざまなタイプで市販されています。

遺伝子検査市場の動向：

成長全体における遺伝性疾患および慢性疾患の有病率の増加は、遺伝子検査市場の成長を促進する重要な要因です。これはさらに、政府機関や非政府組織（NGO）が遺伝子検査に関して大衆を感化するために実施する数多くの有利なイニシアチブの実施によって支えられています。これに伴い、ファーマコゲノミクスにおける遺伝子検査の広範な利用、すなわち遺伝遺伝子との相互作用後の特定の医薬品に対する身体の反応を調べるための医薬品遺伝子検査が、もう一つの成長促進要因として寄与しています。さらに、コロナウイルス感染症（COVID-19）の突然の大流行により、バーチャル検査やサンプル採取目的の在宅検査キットが広く採用されるようになり、これが市場の成長に寄与しています。DTC-GT（消費者直接遺伝子検査）キットのイントロダクションとともに、遺伝子検査技術の飛躍的な技術進歩が市場成長をさらに促進しています。その他の要因としては、医学分野における研究開発（R&D）活動への投資の増加や、先進的な個別化遺伝子検査キットを発売するためのトップ企業間の戦略的提携などがあり、市場に明るい見通しをもたらしています。

本レポートで扱う主な質問

  • 世界の遺伝子検査市場はこれまでどのように推移してきたか？
  • COVID-19が世界の遺伝子検査市場に与えた影響は？
  • 主要な地域市場は？
  • タイプ別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の遺伝子検査市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の遺伝子検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 予測検査と発症前検査
    • 市場動向
    • 市場予測
  • キャリア検査
    • 市場動向
    • 市場予測
  • 出生前・新生児検査
    • 市場動向
    • 市場予測
  • 診断検査
    • 市場動向
    • 市場予測
  • 薬理ゲノム検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • 細胞遺伝学的検査と染色体分析
    • 市場動向
    • 市場予測
  • 生化学検査
    • 市場動向
    • 市場予測
  • 分子検査
    • 市場動向
    • 主要セグメント
      • DNAシーケンス
      • その他
    • 市場予測

第8章 市場内訳：用途別

  • がん診断
    • 市場動向
    • 市場予測
  • 遺伝子疾患診断
    • 市場動向
    • 市場予測
  • 心血管疾患診断
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 23andme Inc.
    • Ambry Genetics Corporation（Konica Minolta Healthcare Americas Inc.）
    • Bio-RAD Laboratories Inc.
    • Cepheid（Danaher Corporation）
    • Eurofins Scientific
    • Illumina Inc.
    • Invitae Corporation
    • Luminex Corporation（DiaSorin）
    • Myriad Genetics Inc.
    • QIAGEN
    • Quest Diagnostics
    • Thermo Fisher Scientific
図表

List of Figures

  • Figure 1: Global: Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Genetic Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Genetic Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Genetic Testing Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Genetic Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Genetic Testing Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Genetic Testing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Genetic Testing (Carrier Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Genetic Testing (Carrier Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Genetic Testing (Prenatal and Newborn Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Genetic Testing (Prenatal and Newborn Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Genetic Testing (Diagnostic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Genetic Testing (Diagnostic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Genetic Testing (Pharmacogenomic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Genetic Testing (Pharmacogenomic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Genetic Testing (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Genetic Testing (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Genetic Testing (Biochemical Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Genetic Testing (Biochemical Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Genetic Testing (Molecular Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Genetic Testing (Molecular Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Genetic Testing (Cancer Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Genetic Testing (Cancer Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Genetic Testing (Genetic Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Genetic Testing (Genetic Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Genetic Testing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Genetic Testing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: North America: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: North America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: United States: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: United States: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Canada: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Canada: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Asia-Pacific: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Asia-Pacific: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: China: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: China: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Japan: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Japan: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: India: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: India: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: South Korea: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: South Korea: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Australia: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Australia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Indonesia: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Indonesia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Others: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Europe: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Europe: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Germany: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Germany: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: France: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: France: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: United Kingdom: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: United Kingdom: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Italy: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Italy: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Spain: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Spain: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Russia: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Russia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Latin America: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Latin America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Brazil: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Brazil: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Mexico: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Mexico: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Others: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Middle East and Africa: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Middle East and Africa: Genetic Testing Market: Breakup by Country (in %), 2022
  • Figure 82: Middle East and Africa: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Global: Genetic Testing Industry: SWOT Analysis
  • Figure 84: Global: Genetic Testing Industry: Value Chain Analysis
  • Figure 85: Global: Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genetic Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Genetic Testing Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Genetic Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Genetic Testing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Genetic Testing Market: Competitive Structure
  • Table 7: Global: Genetic Testing Market: Key Players
目次
Product Code: SR112023A5788

Market Overview:

The global genetic testing market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 29.0 Billion by 2028, exhibiting a growth rate (CAGR) of 10.37% during 2023-2028.

Genetic testing, or deoxyribonucleic acid (DNA) testing, refers to a medical technique that identifies changes in the chromosome structure or DNA sequence. It includes the collection and analysis of individual blood samples for examining the genetic condition and the chances of developing or passing various inherited disorders in laboratory settings. Genetic testing assists in providing accurate results regarding gene mutation, eliminating the need for unnecessary checkups, and making informed decisions to manage health. At present, genetic testing is commercially available in varying types, such as carrier, diagnostic, predictive, presymptomatic and prenatal testing.

Genetic Testing Market Trends:

The increasing prevalence of genetic and chronic disorders across the growth represents the key factor driving the genetic testing market growth. This is further supported by the implementation of numerous favorable initiatives undertaken by the government bodies and non-governmental organizations (NGOs) for sensitizing masses regarding genetic testing. In line with this, the extensive utilization of genetic testing in pharmacogenomics, or drug-gene testing for examining the response of the body against certain medicines after its interaction with inherited genes, is contributing as another growth-inducing factor. Additionally, the sudden outbreak of coronavirus disease (COVID-19) pandemic has led to the widespread adoption of virtual testing and the home testing kits for sample collection purposes, which, in turn, is contributing to the market growth. The tremendous technological advancements in genetic testing techniques along with the introduction of DTC-GT (Direct-to-consumer genetic testing) kits are further propelling the market growth. Other factors, such as rising investments in the research and development (R&D) activities in the field of medical science, along with the strategic collaboration amongst top players for launching advanced personalized genetic testing kits, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genetic testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology and application.

Breakup by Type:

Predictive and Presymptomatic Testing

Carrier Testing

Prenatal and Newborn Testing

Diagnostic Testing

Pharmacogenomic Testing

Others

Breakup by Technology:

Cytogenetic Testing and Chromosome Analysis

Biochemical Testing

Molecular Testing

DNA Sequencing

Others

Breakup by Application:

Cancer Diagnosis

Genetic Disease Diagnosis

Cardiovascular Disease Diagnosis

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.

Key Questions Answered in This Report:

  • How has the global genetic testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global genetic testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genetic testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Predictive and Presymptomatic Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Carrier Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Prenatal and Newborn Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostic Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pharmacogenomic Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cytogenetic Testing and Chromosome Analysis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biochemical Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 DNA Sequencing
      • 7.3.2.1 Others
    • 7.3.3 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Genetic Disease Diagnosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 23andme Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cepheid (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Invitae Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Luminex Corporation (DiaSorin)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Myriad Genetics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis